Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

August 17, 2021

Study Completion Date

December 10, 2021

Conditions
Pharmacological Action
Interventions
DRUG

intra-vitreal triamcinolone-moxifloxacin injection after cataract surgery as a prophylactic measures against post-operative endophthalmitis

At the end of surgery, 4mg triamcinolone acetonide and 0.2mg moxifloxacin from 0.5 moxifloxacin preservative-free eye drop) were injected once inferotemporally 3.5 mm posterior to the limbus via pars plana into the vitreous cavity by using 30 G needle.

Trial Locations (1)

Unknown

Emad AbdelAal Saliem, Ţahţā

All Listed Sponsors
lead

Emad Abdel Aal Saliem

OTHER

NCT05428683 - Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery | Biotech Hunter | Biotech Hunter